Graduate Institute of Nanomedicine and Medical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei 11031, Taiwan.
High-value Biomaterials Research and Commercialization Center, National Taipei University of Technology, Taipei 10608, Taiwan.
ACS Biomater Sci Eng. 2024 Jun 10;10(6):3548-3567. doi: 10.1021/acsbiomaterials.3c01978. Epub 2024 May 7.
The conception of vascularized organ-on-a-chip models provides researchers with the ability to supply controlled biological and physical cues that simulate the dynamic microphysiological environment of native blood vessels. The intention of this niche research area is to improve our understanding of the role of the vasculature in health or disease progression by allowing researchers to monitor angiogenic responses and cell-cell or cell-matrix interactions in real time. This review offers a comprehensive overview of the essential elements, including cells, biomaterials, microenvironmental factors, microfluidic chip design, and standard validation procedures that currently govern angiogenesis-on-a-chip assemblies. In addition, we emphasize the importance of incorporating a microvasculature component into organ-on-chip devices in critical biomedical research areas, such as tissue engineering, drug discovery, and disease modeling. Ultimately, advances in this area of research could provide innovative solutions and a personalized approach to ongoing medical challenges.
血管化器官芯片模型的概念为研究人员提供了供应受控生物和物理线索的能力,这些线索模拟了天然血管的动态微生理环境。这个利基研究领域的目的是通过允许研究人员实时监测血管生成反应和细胞-细胞或细胞-基质相互作用,来提高我们对血管在健康或疾病进展中作用的理解。
这篇综述全面概述了目前控制血管生成芯片组件的基本要素,包括细胞、生物材料、微环境因素、微流控芯片设计和标准验证程序。此外,我们强调了在组织工程、药物发现和疾病建模等关键生物医学研究领域将微血管组件纳入器官芯片设备的重要性。
最终,该研究领域的进展可以为正在面临的医疗挑战提供创新的解决方案和个性化的方法。